Combinib (Lapatinib)

Overview

Combinib (Lapatinib) is an oral medication used primarily for the treatment of certain types of breast cancer. It works by inhibiting specific proteins that promote cancer cell growth, making it a targeted therapy option for patients.

Benefits

• Targets specific cancer cells, minimizing damage to healthy cells.
• Can be used in combination with other cancer treatments.
• Helps to slow the progression of breast cancer in patients with HER2-positive tumors.

Dosage

The recommended dosage of Combinib (Lapatinib) is typically 1,250 mg taken orally once daily. It is important to follow your healthcare provider's instructions regarding dosage adjustments and duration of treatment.

Side Effects

• Diarrhea
• Nausea and vomiting
• Fatigue
• Rash
• Heart-related issues

Patients are advised to report any severe side effects to their healthcare provider promptly.

FAQs

What should I do if I miss a dose?

If you miss a dose of Combinib (Lapatinib), take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at once.

Can Combinib be taken with food?

Yes, Combinib (Lapatinib) can be taken with or without food. However, taking it consistently in the same manner (either always with food or always without food) is recommended for optimal absorption.

Is Combinib safe during pregnancy?

Combinib (Lapatinib) is not recommended for use during pregnancy due to potential risks to the fetus. Discuss with your doctor if you are pregnant or planning to become pregnant.